JE

Justin T. Ernst

ET Effector Therapeutics: 15 patents #1 of 24Top 5%
YU Yale University: 2 patents #418 of 1,662Top 30%
📍 San Diego, CA: #1,993 of 23,606 inventorsTop 9%
🗺 California: #27,156 of 386,348 inventorsTop 8%
Overall (All Time): #201,031 of 4,157,543Top 5%
21
Patents All Time

Issued Patents All Time

Showing 1–21 of 21 patents

Patent #TitleCo-InventorsDate
12258332 ASGPR cell surface receptor binding compounds and conjugates Brett B. Busch, Garrick Packard, Jason G. Lewis, Eric D. Turtle 2025-03-25
11952375 Crystalline forms of Mnk inhibitors Siegfried H. Reich, Paul A. Sprengeler, Stephen E. Webber, Alan X. Xiang, Bennett C. Borer +2 more 2024-04-09
11878015 Piperidine-substituted Mnk inhibitors and methods related thereto Paul A. Sprengeler, Siegfried H. Reich, Samuel Sperry 2024-01-23
11440917 EIF4A-inhibiting compounds and methods related thereto Siegfried H. Reich, Paul A. Sprengeler, Chinh Viet Tran, Garrick Packard, Alan X. Xiang +2 more 2022-09-13
11286268 EIF4E-inhibiting compounds and methods Samuel Sperry, Alan X. Xiang, Siegfried H. Reich, Paul A. Sprengeler, Mike Shaghafi +7 more 2022-03-29
11130757 Crystalline forms of MNK inhibitors Siegfried H. Reich, Paul A. Sprengeler, Stephen E. Webber, Alan X. Xiang, Bennett C. Borer +2 more 2021-09-28
11083727 Piperidine-substituted Mnk inhibitors and methods related thereto Paul A. Sprengeler, Siegfried H. Reich, Samuel Sperry 2021-08-10
11014926 Pyrrolo-, pyrazolo-, imidazo-pyrimidine and pyridine compounds that inhibit MNK1 and MNK2 Paul A. Sprengeler, Siegfried H. Reich, Stephen E. Webber 2021-05-25
10793551 Benzimidazole-indole inhibitors of Mnk1 and Mnk2 Siegfried H. Reich, Paul A. Sprengeler, Alan X. Xiang 2020-10-06
10577378 EIF4A-inhibiting compounds and methods related thereto Siegfried H. Reich, Paul A. Sprengeler, Chinh Viet Tran, Garrick Packard, Alan X. Xiang +2 more 2020-03-03
10112955 Isoindoline, azaisoindoline, dihydroindenone and dihydroazaindenone inhibitors of Mnk1 and Mnk2 Paul A. Sprengeler, Siegfried H. Reich, Stephen E. Webber, Mike Shaghafi, Douglas E. Murphy +1 more 2018-10-30
10000487 Heterocyclic compounds that inhibit the kinase activity of Mnk useful for treating various cancers Paul A. Sprengeler, Seigfried H. Reich, Stephen E. Webber 2018-06-19
9957277 eIF4A-inhibiting compounds and methods related thereto Siegfried H. Reich, Paul A. Sprengeler, Chinh Viet Tran, Garrick Packard, Alan X. Xiang +2 more 2018-05-01
9814718 MNK inhibitors and methods related thereto Siegfried H. Reich, Paul A. Sprengeler, Stephen E. Webber, Alan X. Xiang 2017-11-14
9669031 MNK inhibitors and methods related thereto Siegfried H. Reich, Paul A. Sprengeler, Stephen E. Webber, Alan X. Xiang 2017-06-06
9382248 Mnk inhibitors and methods related thereto Siegfried H. Reich, Paul A. Sprengeler, Stephen E. Webber, Alan X. Xiang 2016-07-05
7919617 Cytokine inhibitors Erik Boman, Susana Conde Ceide, Russell Dahl, Nancy Delaet, Antonio Garrido Montalban +8 more 2011-04-05
7897599 Cytokine inhibitors Erik Boman, Susana Conde Ceide, Russell Dahl, Nancy Delaet, Antonio Garrido Montalban +8 more 2011-03-01
7749999 Alpha-ketoamides and derivatives thereof Erik Boman, Susana Conde Ceide, Russell Dahl, Nancy Delaet, Antonio Garrido Montalban +7 more 2010-07-06
7312246 Proteomimetic compounds and methods Andrew D. Hamilton, Brendan P. Orner 2007-12-25
6858600 Proteomimetic compounds and methods Andrew D. Hamilton, Brendan P. Orner 2005-02-22